written on 05.11.2013

GSK reveals two-dose Cervarix data


Cervarix is currently approved in the EU and US for use in females from the age of nine years administered in a three-dose schedule at zero, one and six months. GSK says that the new schedule is intended as an alternative in the nine-to-14 year age…